Purpose: The purpose of the study is to investigate the clinical featu
res and management of ocular ischemic syndrome (OIS) and factors influ
encing its development. Intervention: The following interventions were
used: detailed medical and ocular histories, complete ophthalmic eval
uation including fluorescein angiography, internal carotid artery eval
uation by duplex ultrasonography, and/or aortic arch angiography, mana
gement, and follow-up. Main outcome Measures: The following outcome me
asures were considered: visual acuity, visual fields, intraocular pres
sure, anterior segment neovascularization and other abnormalities, len
s, optic disc, retinal and choroidal changes, carotid artery stenosis
or occlusion, diabetes mellitus, arterial hypertension, coronary arter
y disease, and cerebrovascular disease. Results: Mean age of the 32 pa
tients (39 eyes) with OIS was 68 +/- 8 years. Presenting visual sympto
ms included amaurosis fugax (15%): and/or gradual (28%) or sudden (41%
) visual loss. At initial visit, eyes with OIS had visual acuity less
than or equal to 20/400 in 64%, iris neovascularization (NV) in 87%, a
ngle NV in 59%, intraocular pressure from 4 to 60 mmHg (median, 18 mmH
g), optic disc pale (40%) and/or cupped (19%) or edematous (8%), disc
NV (13%), retinal NV (3%), marked retinal circulatory stasis (21%), an
d retinal hemorrhages (24%). Associated systemic diseases in these pat
ients included diabetes mellitus (56%), arterial hypertension (50%), c
oronary artery disease (38%), and previous stroke or transient ischemi
c attack (31%); the incidence of diabetes, coronary artery disease, an
d cerebrovascular disease was much higher in patients with OIS than in
the comparable general population, especially that of diabetes. Occlu
sion or severe stenosis (80%-99%) of the internal carotid artery was s
een in 74% on the side of OIS. Conclusions: Ocular ischemic syndrome h
as a poor visual prognosis. However, the ophthalmologist's diagnosis m
ay be crucial to the health of these patients, because OIS may be the
presenting sign of serious cerebrovascular and ischemic heart diseases
.